Alyssum Therapeutics Presents Phase 1 Results for First-in-Class CMTR2 Inhibitor AT-1965 at EORTC-NCI-AACR
November 19, 2026

November 19, 2026
November 11, 2026
November 10, 2026
November 10, 2026
October 28, 2026
October 28, 2026
October 27, 2026
October 22, 2026
October 6, 2026
November 19, 2026
Alyssum Therapeutics Inc., a clinical stage biopharmaceutical company developing a pipeline of first in class therapeutics through a patented technolo...
November 11, 2026
Sciensus, a leading European life sciences organisation focused on accelerating patients' access to life-saving medicines, will present three posters ...
November 10, 2026
AI-ready data by design: Standardized, quality-controlled and reproducible quantitative proteomics data, built for integration into large-scale and AI...

Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225